The significance of fitoestrogens in the light of currant knowledge;Znaczenie fitoestrogenów w świetle obecnej wiedzy

Przeglad Menopauzalny

Volumn 4, Issue 4, 2005, Pages 47-50

  Rotsztejn, Helena ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Fitoestrogens; Menopause

Indexed keywords

CHOLESTEROL; DAIDZEIN; ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; GLYCITEIN; ISOFLAVONE; PHYTOESTROGEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CHOICE; HORMONE STRUCTURE; HORMONE SUBSTITUTION; HOT FLUSH; HYPERCHOLESTEROLEMIA; MEDICINAL PLANT; MENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; STRUCTURE ACTIVITY RELATION; TREATMENT INDICATION;

EID: 25444482410     PISSN: 16438876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994; 42: 1666-73.
2. Grynkiewicz G, Gadzikowska M. Fitoestrogeny jako selecktwyne modulatory aktywności repceptorów estrogennych. Postepy Fitoterapii 2003; 10: 28-35.
3. Alberatzzi P, Pansini F, Bonaccorsi G, et al. The effects of soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11.
4. Murkies AL, Lombard C, Strauss B, et al. Dietary flower suplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189-95.
5. Alekel DL, Germain AS, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000; 72 (3): 844-52.
6. Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68 (6 Suppl): 1375S-1379S.
7. Anderson JW, Johnstone BM, Cook-Newell ME. Meta - analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-82.
8. Crouse JR, Morgan T, Terry JG, et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999; 159: 2070-6.
9. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125: 6065-115.
10. Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol 1991; 39: 475-80.
11. Kim H, Peterson T, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 1998; 68 (6 Suppl): 1418S-1425S.
12. Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar F. Inactivation of NF-kappaBeta by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003; 22: 4702-9.
13. Pool-Zobel B, Adlercreutz H, Glei M, et al. Isoflavonoids and lignans have different potentials to modulate oxidative genetic damage in human colon cells. Carcinogenesis 2000; 21: 1247-52.
14. Wei H, Bowen R, Cai Q, et al. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995; 208: 124-9.
15. Horn-Poss PL, John E M, Canchola AL, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer I 2003; 95 (15): 1158-64.
16. Mishra SI, Dickerson V, Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J Obset Gynecol 2003: 188 (5): 566-70.
17. Joannou GE, Kelly GE, Reeder AY, et al. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J Steroid Biochem Mol Biol 1995; 54: 167-84.
18. Kelly GE, Nelson C, Waring MA, et al. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993; 223: 9-22.
19. Divi RL, Chang HC, Doerge DR. Antithyroid isoflavones from soybean. Biochem Pharmacol 1997; 54: 1087-96.